Posts Tagged ‘on-x heart valve’

“My On-X Valves have been great!”

“The On-X valves have been great. I have two of your valves–aortic and mitral. They are not too loud and do not keep me or my wife awake at night. I had surgery to replace my aortic and mitral valves in November of 2006. I researched heart valves on the internet and talked with patients…

Read More

“The On-X Valve was just what I had surmised”

“I opted for an aortic valve repair 8.5 years ago because I was hoping that a new improved mechanical valve would come along before I needed my next operation. The repair worked for a little over 8 years and fortunately, the on-x valve was just what I had surmised and hoped would come to market.…

Read More

“If I had it to do again would I choose an On-X valve? ABSOLUTELY”

In October of 2010, I was diagnosed with a congenital atrial valve defect requiring surgery. My surgeon and cardiologist were both extremely detailed in what was needed and gave me the opportunity to research each option and then meet with the surgeon again to agree on the time, process etc. After researching the mechanical valve…

Read More

“Every medical professional I consulted recommended the On-X valve”

I was born with a bicuspid aortic valve, which developed stenosis and calcification over the last 23 years. After it was determined that I needed my valve replaced, every medical professional I consulted recommended the On-X valve. They all recommended it because it is a permanent valve replacement solution, requiring no future surgeries, and also…

Read More

On-X Heart Valve Study Results

Presented at the Society for Heart Valve Disease 7th Biennial Congress Two PROACT Abstracts Present Data Showing Patients on Low Anticoagulation Therapy Do Well with the On-X® Prosthetic Heart Valve AUSTIN, TX — June 25, 2013 — On-X® Life Technologies, Inc. (On-X LTI) announced today that two new PROACT abstracts further demonstrating the safety of…

Read More

Enrollment Completed

Low-Risk Aortic and Mitral Patient Groups for On-X Prosthetic Heart Valve Anticoagulation Clinical Study Low-risk aortic valve patients are maintained with aspirin and clopidogrel only AUSTIN, TX – May 7, 2013 – On-X® Life Technologies, Inc. (On-X LTI) announced today that enrollment for the Low-Risk Aortic Valve and Mitral Valve Patient Groups has been completed.…

Read More

AATS Report: PROACT

Prospective Randomized On-X Heart Valve Clinical Trial Provides Evidence of Reduced Complications On-X aortic valve trial is the first to formally study patients maintained at levels of anticoagulation below those currently recommended by professional society guidelines, helping to lessen anticoagulation-related complications AUSTIN, TX – May 6, 2013 – On-X® Life Technologies, Inc. (On-X LTI) announced…

Read More

Clinical Update Forty-Four: Valve Choice

Valve Choice Has Long-Term Complication and Cost Implications for Patients and Healthcare Providers Comparative long-term cost model shows choosing the On-X heart valve for implantation in young patients could save: $59,000 over choosing a stented tissue (ST) valve with ST at re-op1, $376,000 over choosing a stented tissue (ST) valve with TAVI/ ViV at re-op1…

Read More

Predicting Long-Term Costs

Heart Valve Replacement Study to be Presented at American College of Cardiology Meeting A comparative long-term cost analysis between the On-X® Prosthetic Heart Valve and stented tissue valves shows a potential life-time savings of nearly $60,000 per patient and $1.2 billion for total U.S. healthcare AUSTIN, TX – March 8, 2013 – On-X® Life Technologies,…

Read More
Onxlti Responsive Menu
Menu